| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |